Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-02-28 @ 12:18 AM
Study NCT ID:
NCT02721966
Status:
COMPLETED
Last Update Posted:
2020-10-01
First Post:
2016-03-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Axial Psoratic Arthritis | View |